The Epithelioid Sarcoma market, estimated to be valued at USD 1.57 Billion in 2025, is anticipated to exhibit a strong CAGR of 9.3%, reaching USD 2.93 Billion by 2032. Market growth is primarily driven by the rising prevalence of rare soft tissue sar...
The global PV inverters market size is expected to be worth USD 18.98 Billion in 2025. It can surge to a valuation of USD 62.28 Billion by 2032. The market is anticipated to exhibit a robust CAGR of 18.5% during the forecast period (2025-2032). ...
The Pulmonary Hypertension Drugs Market, estimated to be valued at USD 8.69 Billion in 2025, is expected to exhibit a strong CAGR of 7.3%, reaching USD 14.23 Billion by 2032. The market growth is driven by the rising prevalence of pulmonary arterial...
The global solar water heaters market size is expected to be worth USD 6.57 Billion in 2025. It can surge to a valuation of USD 9.75 Billion by 2032. The market is anticipated to exhibit a robust CAGR of 5.8% during the forecast period (2025-2032). &...
The Gastrointestinal Stromal Tumor (GIST) market, estimated to be valued at USD 1.32 billion in 2025, is projected to exhibit a robust CAGR of 9.8%, reaching USD 2.54 billion by 2032. Market growth is primarily driven by the increasing prevalence of ...
The global thermostat market size is expected to be worth USD 7.32 Billion in 2025. It can scale to a value of USD 17.33 Billion by 2032. The market is anticipated to exhibit a robust CAGR of 13.1% during the forecast period (2025-2032). The ...
The Chondrosarcoma market, estimated to be valued at USD 1,028.5 Million in 2025, is expected to grow at a robust CAGR of 7.0%, reaching USD 1,651.6 Million by 2032. Market expansion is driven by the rising incidence of rare bone cancers, increasing...
The global genome editing market size is expected to be worth USD 4.4 Billion in 2025. It can surge to a valuation of USD 10.22 Billion by 2032. The market is anticipated to exhibit a robust CAGR of 12.8% during the forecast period (2025-2032). ...
The Von Hippel-Lindau Disease market, estimated to be valued at USD 325.3 Million in 2025, is projected to exhibit a strong CAGR of 8.0%, reaching USD 557.5 Million by 2032. Market growth is being fueled by the increasing adoption of precision oncol...
The retinitis pigmentosa market, estimated to be valued at USD 542.8 Million in 2025, is projected to exhibit a CAGR of 6.4%, reaching USD 838.0 Million by 2032. This growth is primarily driven by advancements in gene and cell-based therapies, as wel...